Aggregate Biosciences

Aggregate Biosciences is pioneering a revolutionary approach to prevent Alzheimer’s disease by targeting its connection with type 2 diabetes. We’ve identified that amyloid aggregates, which spread from peripheral tissues to the brain, are a crucial link between these devastating diseases. Our breakthrough platform combines advanced diagnostics with precision therapeutics to intercept this spread before it reaches the central nervous system. By addressing this critical disease pathway early in type 2 diabetes patients, we’re not only improving diabetes care but potentially preventing Alzheimer’s development – tackling two global health crises with one innovative solution.